http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Grapefruit Seed Extract ( DF-100 ) Treatment of Poultry to Reduce Attached Salmonella
Jeong-Weon Kim,Phil L. Matsler,Hong Wang,Mike F. Slavik 한국식품위생안전성학회 1996 한국식품위생안전성학회지 Vol.11 No.1
Chicken skins or carcasses inoculated with Salmonella typhimurium were exposed to 0.1 or 0.5% grapefruit seed extracts (DF-100) for 1 or 3 min to evaluate antibacterial activity of DF-100 and its possible application in proultry processing. The numbers of live salmonellae on chicken skins were reduced by 0.8-1.2 logs/㎠ with 0.1% and by 1.6-1.7 logs/㎠ with 0.5% DF-100. Dipping chicken carcasses into 0.5% DF-100 for 3 min reduced salmonellae by 4.3 logs/ carcass. Scanning electron microaoopy showed that DF-100 killed the cells attached but did not detach cells from the skin. No odor or changes in the color of chicken skin were detected after DF-100 treatment.
왕덕현,김원일,엄필환,Wang, Duck Hyun,Kim, Won Il,Eom, Phil Hwan 한국기계가공학회 2003 한국기계가공학회지 Vol.2 No.1
The experimental study for turning circular free fanned surface with TiN coated insert tool was conducted for different cutting conditions such as cutting speed, feed rate and depth-of-cut. For the fluctuation of 1.0mm depth-of-cut, the characteristics for machined surface and tool wear were less influenced by the feed rate and cutting speed than those of higher depth of cut. The higher surface roughness and surface precision were obtained in lower cutting speed. For the fluctuation of 1.5mm depth-of-cut, the higher surface roughness was obtained for the case of the lower feed rate of 0.05-10mm/rev and the higher cutting speed of 80m/min. For the fluctuation of 2.0mm depth-of-cut, the surface roughness and surface precision were too worse to machine the specimen And the flank wear on the tool was increased rapidly rather than the crater wear.
Zhang, Wei,Shin, Eun‐,Joo,Wang, Tongguang,Lee, Phil Ho,Pang, Hao,Wie, Myung‐,Bok,Kim, Won‐,Ki,Kim, Seong‐,Jin,Huang, Wen‐,Hsin,Wang, Yongjun,Zhang, Wanqin,Hong, Jauȁ Federation of American Society for Experimental Bi 2006 The FASEB Journal Vol.20 No.14
<P>We investigated the neuroprotective property of analogs of dextromethorphan (DM) in lipopolysaccharide (LPS) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models to identify neuroprotective drugs for Parkinson's disease (PD). In vivo studies showed that daily injections with DM analogs protected dopamine (DA) neurons in substantia nigra pars compacta and restored DA levels in striatum using two different models for PD. Of the five analogs studied, 3-hydroxymorphinan (3-HM), a metabolite of DM, was the most potent, and restored DA neuronal loss and DA depletion up to 90% of the controls. Behavioral studies showed an excellent correlation between potency for preventing toxin-induced decrease in motor activities and neuroprotective effects among the DM analogs studied, of which 3-HM was the most potent in attenuating behavioral damage. In vitro studies revealed two glia-dependent mechanisms for the neuroprotection by 3-HM. First, astroglia mediated the 3-HM-induced neurotrophic effect by increasing the gene expression of neurotrophic factors, which was associated with the increased acetylation of histone H3. Second, microglia participated in 3-HM-mediated neuroprotection by reducing MPTP-elicited reactive microgliosis as evidenced by the decreased production of reactive oxygen species. In summary, we show the potent neuroprotection by 3-HM in LPS and MPTP PD models investigated. With its high efficacy and low toxicity, 3-HM may be a novel therapy for PD.</P>
Jae Young Seong,Kaushik Maiti,Jian Hua Li,Ai Fen Wang,Sujata Acharjee,Wang Phil Kim,임욱빈,권혁방 한국분자세포생물학회 2003 Molecules and cells Vol.16 No.2
ecently, we identified three types of non-mammalian gonadotropin-releasing hormone receptors (GnRHR) in the bullfrog (designated bfGnRHR-1-3), and a mammalian type-II GnRHR in green monkey cell lines (denoted gmGnRHR-2). All these receptors responded better to GnRH-II than GnRH-I, while mammalian type-I GnRHR showed greater sensitivity to GnRH-I than GnRH-II. In the present study, we designed new GnRH-II analogs and examined whether they acti- vated or inhibited non-mammalian and mammalian type-II GnRHRs. [D-Ala 6 ]GnRH-II, with D-Ala substi- tuted for Gly 6 in GnRH-II, increased inositol phos- phate (IP) production in cells stably expressing non- mammalian GnRHRs more effectively than native GnRH-II. However, it exhibited lower activity for mammalian type-I GnRHR than GnRH-I itself. Trptorelix-1, a GnRH-II antagonist, inhibited GnRH- induced IP production in cells expressing non- mammalian GnRHRs more effectively than Cetrorelix, a GnRH-I antagonist. Trptorelix-1, however, had lower potency for mammalian type-I GnRHR than Cetrorelix. Ligand-receptor binding assays revealed that [D-Ala 6 ]GnRH-II and Trptorelix-1 have higher affinities for non-mammalian GnRHRs but lower af- finities for mammalian type-I GnRHR than GnRH-II and Cetrorelix, respectively. Moreover, [D-Ala 6 ]GnRH- II and Trptorelix-1 had a higher affinity for gmGnRHR-2 than GnRH-II and Cetrorelix, respec- tively. These results indicate that [D-Ala 6 ]GnRH-II and Trptorelix-1 are highly effective agonist and antagonist, respectively, for non-mammalian and type- II mammalian GnRHRs